Marta Gazal1, Karen Jansen2, Luciano D Souza2, Jean P Oses2, Pedro V Magalhães3, Ricardo Pinheiro2, Gabriele Ghisleni2, Luciana Quevedo2, Manuella P Kaster4, Flávio Kapczinski3, Ricardo A da Silva2. 1. Graduate Program in Cellular and Molecular Biology, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. 2. Graduate Program in Health and Behavior, Universidade Católica de Pelotas, Pelotas, RS, Brazil. 3. Molecular Psychiatry Laboratory, National Science and Technology Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 4. Department of Biochemistry, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
Abstract
OBJECTIVE: To investigate peripheral levels of interleukin-10 (IL-10) in patients with major depressive disorder (MDD) and bipolar disorder (BD) and evaluate the relationship between IL-10, age of disease onset, and duration of illness. METHODS: Case-control study nested in a population-based cohort of 231 individuals (age 18-24 years) living in Pelotas, state of Rio Grande do Sul, Brazil. Participants were screened for psychopathology using the Mini-International Neuropsychiatric Interview (MINI) and the Structured Clinical Interview for DSM-IV (SCID-I). Serum IL-10 was measured using commercially available immunoassay kits. RESULTS: Peripheral levels of IL-10 were not significantly different in individuals with MDD or BD as compared to controls. However, higher IL-10 levels were found in MDD patients with a later disease onset as compared with controls or early-onset patients. In addition, IL-10 levels correlated negatively with illness duration in the MDD group. In the BD group, age of onset and duration of illness did not correlate with IL-10 levels. CONCLUSION: Higher levels of IL-10 are correlated with late onset of MDD symptoms. Moreover, levels of this cytokine might decrease with disease progression, suggesting that an anti-inflammatory balance may be involved in the onset of depressive symptoms and disease progression in susceptible individuals.
OBJECTIVE: To investigate peripheral levels of interleukin-10 (IL-10) in patients with major depressive disorder (MDD) and bipolar disorder (BD) and evaluate the relationship between IL-10, age of disease onset, and duration of illness. METHODS: Case-control study nested in a population-based cohort of 231 individuals (age 18-24 years) living in Pelotas, state of Rio Grande do Sul, Brazil. Participants were screened for psychopathology using the Mini-International Neuropsychiatric Interview (MINI) and the Structured Clinical Interview for DSM-IV (SCID-I). Serum IL-10 was measured using commercially available immunoassay kits. RESULTS: Peripheral levels of IL-10 were not significantly different in individuals with MDD or BD as compared to controls. However, higher IL-10 levels were found in MDDpatients with a later disease onset as compared with controls or early-onset patients. In addition, IL-10 levels correlated negatively with illness duration in the MDD group. In the BD group, age of onset and duration of illness did not correlate with IL-10 levels. CONCLUSION: Higher levels of IL-10 are correlated with late onset of MDD symptoms. Moreover, levels of this cytokine might decrease with disease progression, suggesting that an anti-inflammatory balance may be involved in the onset of depressive symptoms and disease progression in susceptible individuals.
Authors: Sadia Anjum; M M A Shalahuddin Qusar; Mohammad Shahriar; Sardar Mohammad Ashraful Islam; Mohiuddin Ahmed Bhuiyan; Md Rabiul Islam Journal: Ther Adv Psychopharmacol Date: 2020-04-28
Authors: Lucia Carboni; Dennis J McCarthy; Bruno Delafont; Michele Filosi; Elena Ivanchenko; Emiliangelo Ratti; Susan M Learned; Robert Alexander; Enrico Domenici Journal: Transl Psychiatry Date: 2019-08-02 Impact factor: 6.222
Authors: Pabitra Basnyat; Marko Pesu; Mikael Söderqvist; Anna Grönholm; Suvi Liimatainen; Maria Peltola; Jani Raitanen; Jukka Peltola Journal: BMC Neurol Date: 2020-06-12 Impact factor: 2.474